Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Real-World Outcomes of CD19 CAR T-Cell Therapies in Follicular Lymphoma: A Comparative Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel

CT - 1766

Real-World Outcomes of CD19 CAR T-Cell Therapies in Follicular Lymphoma: A Comparative Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel

Sangam Sangam

Poster Presenter: Sangam Sangam

Thumbnail for Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

ABCL - 1431

Real-World Outcomes of Central Nervous System (CNS) Prophylaxis in Diffuse Large B-Cell Lymphoma (DLBCL): A National Multicenter Retrospective Cohort Study

Saurav Das

Poster Presenter: Saurav Das

Previous 1...100 101 102 103 104 105 106...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

ABCL - 286

Real-World Outcomes of Diffuse Large B-Cell Lymphoma: A 7-Year Retrospective Cohort Study from a Tertiary Care Center in a Low- and Middle-Income Country

Shahzeb Ahmed

Poster Presenter: Shahzeb Ahmed

Thumbnail for Real-World Outcomes of Dose-Modified Polatuzumab Vedotin-R-CHP in Older Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Retrospective Study From Northern India

ABCL - 666

Real-World Outcomes of Dose-Modified Polatuzumab Vedotin-R-CHP in Older Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Retrospective Study From Northern India

Ajay Gogia

Poster Presenter: Ajay Gogia

Thumbnail for Real-World Outcomes of Imetelstat: Interrogating Safety, Efficacy, and Predictors of Response in Heavily Pretreated Lower-Risk Patients With MDS

MDS - 646

Real-World Outcomes of Imetelstat: Interrogating Safety, Efficacy, and Predictors of Response in Heavily Pretreated Lower-Risk Patients With MDS

Rami Komrokji

Poster Presenter: Rami Komrokji

$Thumbnail for Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma$

MCL - 906

Real-World Outcomes of Lisocabtagene Maraleucel in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma

Sally Jones*

Poster Presenter: Sally Jones*

Thumbnail for Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

CLL - 916

Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

MM - 1031

Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

Abat Khan

Poster Presenter: Abat Khan

Thumbnail for Real-World Outcomes of Secondary Hemophagocytic Lymphohistiocytosis in B-Cell Versus T/NK-Cell Lymphomas: A Propensity-Matched Study

TCL - 1219

Real-World Outcomes of Secondary Hemophagocytic Lymphohistiocytosis in B-Cell Versus T/NK-Cell Lymphomas: A Propensity-Matched Study

Muzammil Dastagir

Poster Presenter: Muzammil Dastagir

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors